Vision And Nerve Growth Restored By Biosynthetic Corneas Formulated With Recombinant Collagen
FibroGen, Inc., has announced results of a 2-year clinical study demonstrating that surgical implantation of biosynthetic corneas formulated with the company’s proprietary recombinant human type III collagen (rhCIII) restored vision and promoted nerve regeneration (restoring sensitivity) in patients who had corneal damage and significant vision loss…
More: continued here
Filed under: Eye Health on September 5th, 2010
You must be logged in to post a comment.